Capricor Therapeutics (CAPR) Cash from Investing Activities (2016 - 2025)
Historic Cash from Investing Activities for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $16.0 million.
- Capricor Therapeutics' Cash from Investing Activities rose 69570.14% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$69.0 million, marking a year-over-year decrease of 526736.88%. This contributed to the annual value of -$116.2 million for FY2024, which is 237445.36% down from last year.
- Per Capricor Therapeutics' latest filing, its Cash from Investing Activities stood at $16.0 million for Q3 2025, which was up 69570.14% from $14.5 million recorded in Q2 2025.
- In the past 5 years, Capricor Therapeutics' Cash from Investing Activities registered a high of $23.9 million during Q1 2025, and its lowest value of -$123.4 million during Q4 2024.
- In the last 5 years, Capricor Therapeutics' Cash from Investing Activities had a median value of -$322459.0 in 2021 and averaged -$4.9 million.
- Over the last 5 years, Capricor Therapeutics' Cash from Investing Activities had its largest YoY gain of 149477.09% in 2022, and its largest YoY loss of 1088205.14% in 2022.
- Capricor Therapeutics' Cash from Investing Activities (Quarter) stood at -$368671.0 in 2021, then surged by 1494.77% to $5.1 million in 2022, then tumbled by 214.01% to -$5.9 million in 2023, then tumbled by 2004.53% to -$123.4 million in 2024, then surged by 112.93% to $16.0 million in 2025.
- Its last three reported values are $16.0 million in Q3 2025, $14.5 million for Q2 2025, and $23.9 million during Q1 2025.